About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘china retractions’ Category

“Lack of experience and understanding” forces duplication retractions of liver cancer paper

with one comment

dovelogoA group of researchers in China has lost their paper on liver cancer after the first author admitted to duplication, also known, inelegantly, as self-plagiarism.

The paper, “Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells,” appeared in the July 2013 issue of the Journal of Drug Design, Development and Therapy, a Dove Press title.

According to the abstract: Read the rest of this entry »

About these ads

Rice researcher in ethics scrape threatens journal with lawsuit over coming retraction

with 6 comments

Guangwen Tang, a rice researcher at Tufts University, landed in hot water in 2012 after her team was accused of feeding Chinese children genetically modified Golden Rice without having obtained informed consent from the parents.

Now, she’s suing both Tufts and the American Journal of Clinical Nutrition, which reportedly is retracting a paper, “ß-carotene in Golden Rice is as good as p-carotene in oil at providing vitamin A to children,” based on the federally funded research, claiming that the retraction would constitute defamation. (That retraction hasn’t happened yet.)

This isn’t the first time we’ve heard the retraction = defamation line. Readers might remember Ariel Fernandez, who threatened to sue us for writing about an expression of concern. Maybe a course on the Streisand Effect should be mandatory for PhD students?
Read the rest of this entry »

Written by Cat Ferguson

July 17, 2014 at 12:14 pm

Recursive plagiarism? Researchers may have published a duplicate of a study retracted for plagiarism

with 15 comments

acta physica sinicaSometimes plagiarism, like an onion, has layers.

That appears to be the case in a paper brought to our attention by sharp-eyed reader Vladimir Baulin, whose work was copied in a 2006 paper that Journal of Biological Physics retracted for plagiarism.

But you can’t keep a good thief down: the plagiarizing authors just popped up in a new journal with a Chinese-language version of their retracted paper, that looks an awful lot like a knock-off. Here’s a note from Baulin: Read the rest of this entry »

Misconduct prompts retraction of prostatectomy paper

with 2 comments

jsrcoverA group of urologists in China has lost their 2012 paper in the Journal of Surgical Research because one of the authors was evidently rather naughty.

The article, “Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study,” purported to show that: Read the rest of this entry »

Author steps in to clarify vague tuberculosis retraction

with 2 comments

You’ve got to love when an author is willing to detail the specifics of an unhelpful retraction notice.

This May, a paper came out in Journal of Thoracic Diseases about drug-resistant tuberculosis. It was retracted in June, for “some misconduct in the manuscript.”

Here’s the notice:

The article “Application status of MALDI-TOF mass spectrometry in the identification and drug resistance of Mycobacterium tuberculosis” (doi: 10.3978/j.issn.2072-1439.2014.02.19) that appeared on page 512-516 of the May 2014 issue of the Journal of Thoracic Disease needs to be withdrawn due to some misconduct in the manuscript. We are sorry for the inconvenience caused.

Since that’s pretty vague and unhelpful, we reached out to corresponding author Jiayun Liu, who gave us a thorough rundown:

Read the rest of this entry »

If only more retractions could be like this: Authors of cardiac stem cell paper show the way

with 5 comments

Researchers at Qingdao University have fully retracted a paper originally published in Molecular Medicine Reports with a clear, detailed outline of what went wrong and how they discovered the error.

Here’s the notice for “Generation of induced pluripotent stem cells using skin fibroblasts from patients with myocardial infarction under feeder-free conditions:”

Read the rest of this entry »

Wayward “contractor” prompts expression of concern for PLoS ONE paper on cancer cells

with 8 comments

logoThe editors of PLoS ONE have issued an Expression of Concern (which seems likely to become a retraction) for a 2014 paper by a group of researchers in China who claim to have been led astray by a contractor hired to “edit the language” of the report.

The article, “Arsenic Sulfide Promotes Apoptosis in Retinoid Acid Resistant Human Acute Promyelocytic Leukemic NB4-R1 Cells through Downregulation of SET Protein,” came from a group in the Department of Hematology at the First Affiliated Hospital at Xi’an Jiaotong University, and was led by Yuwang Tian, a pathologist at the General Hospital of Beijing Military Area of PLA.

Or at least that’s what the manuscript eventually said. According to the expression of concern, however, that’s not what it said initially: Read the rest of this entry »

If it smells like pig sh@#, it probably is pig sh@#: A stinky retraction

leave a comment »

biores techA group of authors in China has lost their 2011 paper in Bioresource Technology on pig poop because the journal detected a whiff of the familiar in a previously published article by other researchers in the same journal (a major tsk tsk and, well, oops).

The article, “Feasibility of biogas production from anaerobic co-digestion of herbal-extraction residues with swine manure,” came from a team at Nanchang University. Except, well, not really, as we’ll see. According to its abstract:
Read the rest of this entry »

Written by amarcus41

June 20, 2014 at 11:30 am

Recombinant protein paper retracted for recombining others’ work

with one comment

biomed research intThe Journal of Biomedicine and Biotechnology — now BioMed Research International — has retracted a 2012 paper by a group from China who seem really to have admired a related 2007 article by a team from the Scripps Research Institute — and evidently other work, as well.

Here’s the abstract of the now-retracted paper, titled “Stable Plastid Transformation for High-Level Recombinant Protein Expression: Promises and Challenges” (emphasis ours): Read the rest of this entry »

Duplication forces retraction of liver cancer paper

with 4 comments

biomed research intBioMed Research International has retracted a 2013 paper after it became clear that it was lifted from another 2013 paper about the same subject by some of the same authors.

According to the retraction notice: Read the rest of this entry »

Written by amarcus41

June 18, 2014 at 11:30 am

Follow

Get every new post delivered to your Inbox.

Join 33,708 other followers